How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like Atossa Genetics Announces First Quarter 2017 Financial Results And Provides Company Update May 15, 2017 3 Hottest Areas of Drug Development to Keep an Eye on in 2018 December 19, 2017 Groundbreaking: Amicus Surges as the FDA Changes Its Tune on Fabry Disease Drug July 10, 2017
Atossa Genetics Announces First Quarter 2017 Financial Results And Provides Company Update May 15, 2017
